Grazoprevir hydrate - CAS 1350462-55-3

Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medications.

Others, SARS-CoV, HCV Protease

Microbiology/Virology, Others, Proteases/Proteasome

1350404

C38H52N6O10S

784.92

O.COc1ccc2nc3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)N[C@@]4(C[C@H]4C=C)C(=O)NS(=O)(=O)C4CC4)Oc3nc2c1)C(C)(C)C

-20°C

Ice Packs

Small Compound